Market Context
A $32B Market. 90% Independent.
The Differentiator Is the Room.
The US med spa market is growing from $19B to $32B by 2027 — fragmented, cash-pay, and increasingly decided by a single factor: how the room feels. Synthesized from the Solomon Partners MedSpa Market Overview (Q2 2024).
$32B
US MedSpa TAM
by 2027
14.7%
Market CAGR
2023–2027
90%
Independently
owned operators
$536
Average spend
per visit
Market Overview
Scale & Momentum
- 9,400+ US med spa locations in 2023, nearly double the 2018 figure
- Expected to grow to 12,000+ locations by 2027 — a 28% increase
- Market growing within a $1.3T Health & Wellness TAM
- $2M average annual revenue per single-location operator
- 70,000 professionals currently employed across the sector
Who's in the Chair
- 88% of all procedures used by women
- 78% of female customers are under 55 — a young, loyal demographic
- 35–54 is the largest age group, representing 52% of customers
- Customers increase spend and frequency over time, building high LTV
- 95% of customers under 40 arrive with strong product preferences
Tailwinds
The Tailwinds Are Structural, Not Cyclical
Aging Population
Older customers add restorative treatments on top of preventative routines — compounding per-client revenue over time.
Zoom & Appearance Pressure
Remote work normalized a new level of appearance consciousness that has persisted and become baseline behavior.
Cultural Acceptance
Destigmatization across gender and age cohorts. Procedures that were "secret" are now social currency.
GLP-1 / Ozempic Effect
Rapid weight-loss drugs creating downstream demand for skin tightening and body contouring — new patient journeys entering the funnel.
Social Media Loop
Skincare content drives awareness → visits drive content → content drives awareness. The flywheel rewards differentiated experiences.
Skintellectual Demand
Consumers are arriving educated and seeking advanced protocols. The bar for "good enough" keeps rising.
Emerging Science
Peptides: From Pharmaceutical Labs to Aesthetic Practice
Peptides — short chains of 2 to 50 amino acids — are foundational to how the human body regulates itself. Once confined to pharmaceutical research, they are now one of the fastest-growing categories in aesthetic medicine, backed by decades of clinical data and an accelerating pipeline of therapeutic applications.
Peptides govern virtually every physiological process: they regulate metabolic homeostasis, modulate inflammation, support wound healing, defend against pathogens, and serve as the body's primary signaling molecules. That biological specificity is what makes them compelling for aesthetic use — they communicate with skin at a cellular level rather than acting on the surface.
Collagen & Wound Repair
Peptides support mesenchymal cell differentiation and wound healing — the same mechanism that drives collagen-stimulating aesthetic treatments.
Anti-Inflammatory Action
Antimicrobial and anti-inflammatory peptides play documented roles in conditions like rosacea and atopic dermatitis — increasingly relevant as med spas expand into skin health.
Antioxidant Properties
Bioactive peptides exhibit antioxidant capabilities that protect against cellular degradation — a key mechanism in anti-aging and skin longevity protocols.
Precision Targeting
Synthetic peptides can be designed to target specific receptors with high specificity — enabling therapeutic precision that broad-spectrum topicals cannot match.
Hormonal Regulation
Peptide hormones (insulin, oxytocin, natriuretic peptides) demonstrate how this class of molecules governs systemic health — underscoring the legitimacy of peptide-based wellness protocols.
Pharma to Aesthetics Pipeline
The pharmaceutical industry's accelerating shift toward peptide biologics as novel drug candidates is validating and expanding the science available to aesthetic practitioners.
The "skintellectual" consumer — arriving educated and demanding evidence-based protocols — is driving med spas to offer peptide-based treatments as a differentiator. Operators who can speak fluently to the science are building a new category of trust-based loyalty that transactional providers cannot replicate. Source: Peptides, NCBI Bookshelf (NBK562260).
Competitive Landscape
The 90% who compete on
experience, not scale.
Nine in ten med spas are still independently owned. Private equity has been aggressive — 15+ platform acquisitions in 2023 alone — but the vast majority of the market remains founder-led. These operators compete on quality, service breadth, and social presence. They cannot out-spend PE platforms on equipment or marketing.
Their edge is the room itself. How it feels to be in it. The ambient sensory environment is the one experience layer that is low-cost to implement, invisible to PE playbooks, and emotionally memorable enough to drive word-of-mouth.
- Patient experience is a primary value-defining theme flagged by PE investors — it applies equally to independents
- Tech-enabled solutions explicitly cited as a driver of traffic, referrals, and revenue per Solomon Partners
- Loyalty and recurring revenue are top-of-mind investor metrics for high-performing independents
- Diversifying revenue beyond procedures is a key differentiation strategy for high-performing independents